Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 347

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Lichen planus

Not yet recruiting

Efficacy and safety of GIA632 versus placebo in adults with moderate to severe cutaneous lichen planus

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:GIA632

Adenocarcinoma pancreas+1

Not yet recruiting

Diagnostic Performance of [68Ga]Ga-HKG301 PET/CT with FAP-2286 in Patients with Pancreatic Adenocarcinoma and Invasive Lobular Breast Cancer

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:FAP-2286

Compulsive sexual behaviour

Not yet recruiting

Psilocybin‑Assisted Psychotherapy for Adults with Sex Addiction: A Pilot Study

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Subdural haematoma

Not yet recruiting

Effect of Low‑Dose Dexamethasone on Surgical Re‑operation Rate in Adults with Chronic Subdural Hematoma after Burr‑hole Drainage

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone

Obesity+1

Not yet recruiting

Feasibility RCT of tirzepatide plus digital weight‑management program versus behavior change alone in women with obesity and infertility

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Tirzepatide

Phase 2 Study of Weekly Ficerafusp Alfa + Pembrolizumab vs Alternative Dosing in First‑Line Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ficerafusp alfa

Rheumatoid arthritis

Not yet recruiting

Efficacy and safety of subcutaneous infliximab in patients with moderate to severe rheumatoid arthritis on background drug combination

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid

Phase II Study of Gemcitabine Plus Ivonescimab in Adults with Advanced Non‑Small Cell Lung Cancer Resistant to Immunotherapy

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine

Phase 2b Randomized Double‑Blind Study of ALN‑CIDEB in Adults with Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years

Multiple sclerosis

Not yet recruiting

Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Colestyramine

Colorectal adenocarcinoma

Not yet recruiting

Phase 2 Study of ro7589831 with Pembrolizumab vs Pembrolizumab Alone in Adults with Advanced Colorectal Cancer (MSI‑High or dMMR)

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

Angina pectoris

Not yet recruiting

Study of Sublingual Glyceryl Trinitrate Spray to Reduce Angina in Adults with Symptomatic Coronary Artery Disease

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glyceryl Trinitrate
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.